Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (622) Arrow Down
Filter Results: (622) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (622)
    • People  (2)
    • News  (57)
    • Research  (449)
    • Events  (2)
    • Multimedia  (8)
  • Faculty Publications  (395)

Show Results For

  • All HBS Web  (622)
    • People  (2)
    • News  (57)
    • Research  (449)
    • Events  (2)
    • Multimedia  (8)
  • Faculty Publications  (395)
← Page 15 of 622 Results →

    Alex Civetta

    financing matters for innovators in the software, technology, professional services, and biotechnology industries. Since 2021 Alex has been named a Top Lawyer in Corporate Law by Boston Magazine; since 2022, Alex has been nationally... View Details
    Keywords: Legal
    • 07 Dec 2015
    • Research & Ideas

    The Rise of Personalized Entrepreneurial Finance and Other VC Trends

    flow in terms of what areas are hot or not. Biotechnology was very hot in the 80s and 90s, and then there was a long profound downturn. In the last 18 months it’s becoming really hot again with bioinformatics, which combines information... View Details
    Keywords: Re: Josh Lerner; Financial Services; Banking
    • 06 Dec 2021
    • News

    Research Brief: Launching into a Downturn

    labor market—but stays the same for those in more stable job categories. Examining the performance of 3,025 founders and their 1,747 startups in the biotechnology and medical-device sectors during previous economic downturns, Roche and... View Details
    Keywords: Jen McFarland Flint; Publishing Industries (except Internet); Information
    • 01 Jun 2016
    • News

    @Soldiers Field

    diverse, outstanding future leaders and who will go on to make a real difference in the world.” Baker Library’s Historical Collections acquired a trove of archival materials from Genzyme, one of the world’s leading biotechnology firms. A... View Details
    • 01 Dec 1998
    • News

    Novartis AG Establishes Global Research Fund

    Four HBS professors whose international research efforts range from biotechnology in Taiwan to foreign investments in Costa Rica have been named the first Novartis Faculty Fellows. The two-year fellowships, funded by a $2 million gift... View Details
    Keywords: Anne Kavanagh
    • 13 Feb 2023
    • News

    Alumnus Gift Will Nurture Basic, Therapeutic Science

    been a partner of the School for over two decades, and I am delighted to continue to support the HMS community in its important work by helping to modernize these landmark facilities to keep pace with therapeutics innovation." Bertarelli is a former View Details
    • Profile

    Arjun Goyal

    possibilities, Arjun sought “a better understanding of how to go from lab work to medical product” by taking an internship (after fulfilling his medical residency in Sydney, Australia) with Celtic Therapeutics in New York City. One of the first View Details
    • 30 Mar 2021
    • Working Paper Summaries

    Kidney Exchange: An Operations Perspective

    Keywords: by Itai Ashlagi and Alvin E. Roth; Biotechnology; Biotechnology
    • April 1995
    • Teaching Note

    Genzyme Corporation: A Financing History (TN)

    By: Timothy A. Luehrman
    Teaching Note for (9-294-005). View Details
    Keywords: Biotechnology Industry
    Citation
    Purchase
    Related
    Luehrman, Timothy A. "Genzyme Corporation: A Financing History (TN)." Harvard Business School Teaching Note 295-131, April 1995.
    • March 2024
    • Case

    Biomanufacturing Decentralization by Stämm

    By: Paul A. Gompers, Jenyfeer Martínez Buitrago and Mariana Cal
    In Buenos Aires, Argentina, cousins Llamazares and D’Alvia founded Stämm, a startup based on the idea of decentralizing biomanufacturing processes and downsizing biotech facilities. After raising its seed and series A rounds, and while finalizing its series B round in... View Details
    Keywords: Business Model; Business Startups; Entrepreneurship; Venture Capital; Selection and Staffing; Technological Innovation; Science-Based Business; Business Strategy; Commercialization; Growth and Development Strategy; Product Launch; Research and Development; Biotechnology Industry; Latin America; South America; Argentina; Buenos Aires
    Citation
    Educators
    Purchase
    Related
    Gompers, Paul A., Jenyfeer Martínez Buitrago, and Mariana Cal. "Biomanufacturing Decentralization by Stämm." Harvard Business School Case 824-190, March 2024.
    • October 2023 (Revised May 2024)
    • Case

    Thermo Fisher Scientific: Foray into Contract Research

    By: Satish Tadikonda, William Marks and Kevin Emancipator
    After publicly declaring that they would not enter the contract research organization (CRO) business in 2017, Thermo Fisher purchased Pharmaceutical Product Development (PPD), one of the biggest players in the CRO space, in 2021. Much had changed in the intervening... View Details
    Keywords: Mergers and Acquisitions; Customer Focus and Relationships; Corporate Strategy; Organizational Change and Adaptation; Biotechnology Industry
    Citation
    Educators
    Purchase
    Related
    Tadikonda, Satish, William Marks, and Kevin Emancipator. "Thermo Fisher Scientific: Foray into Contract Research." Harvard Business School Case 824-073, October 2023. (Revised May 2024.)
    • November 2016 (Revised December 2016)
    • Supplement

    Anthony Starks at InSiL Therapeutics (B)

    By: Vicki Sato and Gary Pisano
    This case accompanies the (A) case from Anthony Starks's perspective. View Details
    Keywords: Biotech; Management Challenges; R&D; R&D Project Management; Management; Biotechnology Industry; California
    Citation
    Purchase
    Related
    Sato, Vicki, and Gary Pisano. "Anthony Starks at InSiL Therapeutics (B)." Harvard Business School Supplement 617-030, November 2016. (Revised December 2016.)
    • October 2011
    • Case

    Gene Sequencing: Staking a Position in an Expanding Industry

    By: Richard G. Hamermesh, Mara Aspinall and Phillip Andrews
    Towards the end of 2010, companies in the gene sequencing industry were pushing aggressive R&D programs to develop technologies and products in the race to sequence the entire human genome at a cost of $1,000. It remained to be seen when the "$1,000 genome" would... View Details
    Keywords: Genetics; Business Growth and Maturation; Business Plan; Competition; Venture Capital; Biotechnology Industry
    Citation
    Find at Harvard
    Related
    Hamermesh, Richard G., Mara Aspinall, and Phillip Andrews. "Gene Sequencing: Staking a Position in an Expanding Industry." Harvard Business School Case 812-004, October 2011.
    • October 2009 (Revised January 2014)
    • Teaching Note

    Sustainability at Millipore (TN)

    By: Michael W. Toffel
    Teaching Note for [610012]. View Details
    Keywords: Environmental Sustainability; Organizational Structure; Investment; Projects; Performance Improvement; Framework; Measurement and Metrics; Corporate Disclosure; Biotechnology Industry
    Citation
    Purchase
    Related
    Toffel, Michael W. "Sustainability at Millipore (TN)." Harvard Business School Teaching Note 610-013, October 2009. (Revised January 2014.)
    • September 2008 (Revised April 2009)
    • Supplement

    Kevin Sharer at Amgen: Sustaining the High-Growth Company (B)

    By: William W. George
    Kevin Sharer, CEO of Amgen, is assessing the challenges he has faced as a major product came under regulatory scrutiny. View Details
    Keywords: Governing Rules, Regulations, and Reforms; Leadership; Product Development; Biotechnology Industry
    Citation
    Purchase
    Related
    George, William W. "Kevin Sharer at Amgen: Sustaining the High-Growth Company (B)." Harvard Business School Supplement 409-037, September 2008. (Revised April 2009.)
    • 2009
    • Working Paper

    Social Influence Given (Partially) Deliberate Matching: Career Imprints in the Creation of Academic Entrepreneurs

    By: Pierre Azoulay, Christopher C. Liu and Toby E. Stuart
    Actors often match with associates on a small set of dimensions that matter most for the particular relationship at hand. In so doing, they are exposed to unanticipated social influences because counterparts have more interests, attitudes, and preferences than would-be... View Details
    Keywords: Entrepreneurship; Patents; Marketplace Matching; Mathematical Methods; Science-Based Business; Power and Influence; Social and Collaborative Networks; Biotechnology Industry
    Citation
    Read Now
    Related
    Azoulay, Pierre, Christopher C. Liu, and Toby E. Stuart. "Social Influence Given (Partially) Deliberate Matching: Career Imprints in the Creation of Academic Entrepreneurs." Harvard Business School Working Paper, No. 09-136, May 2009.
    • September 2003 (Revised March 2007)
    • Case

    Direvo Biotech AG

    Describes the financing and growth decisions facing Direvo, a young German biotech firm with a customer/partner that wants to become an investor. Also discusses the business model for Direvo's directed evolution technology, with applications in both industrial enzymes... View Details
    Keywords: Business Model; Decisions; Business Exit or Shutdown; Value; Business Startups; Biotechnology Industry; Germany
    Citation
    Educators
    Purchase
    Related
    Roberts, Michael J., Vincent Dessain, and Anders Sjoman. "Direvo Biotech AG." Harvard Business School Case 804-017, September 2003. (Revised March 2007.)
    • April 2002
    • Teaching Note

    Anagene, Inc. TN

    By: Robert S. Kaplan
    Teaching Note for (9-102-030). View Details
    Keywords: Entrepreneurship; Public Ownership; Sales; Production; Forecasting and Prediction; Volume; Governing and Advisory Boards; Cost Accounting; Business or Company Management; Financial Reporting; Strategy; Performance Capacity; Biotechnology Industry
    Citation
    Purchase
    Related
    Kaplan, Robert S. "Anagene, Inc. TN." Harvard Business School Teaching Note 102-078, April 2002.
    • October 2001 (Revised March 2002)
    • Case

    Perlegen Sciences

    By: Linda A. Hill and Nicole Tempest
    As a biotech start-up company involved in studying human genomes, Perlegen needed to develop an organization that fostered innovation and teamwork among a group of highly trained professionals from both the science and technology fields. Perlegen's CEO, Brad Margus,... View Details
    Keywords: Innovation Leadership; Groups and Teams; Management Teams; Problems and Challenges; Business Startups; Genetics; Talent and Talent Management; Innovation Strategy; Biotechnology Industry
    Citation
    Educators
    Purchase
    Related
    Hill, Linda A., and Nicole Tempest. "Perlegen Sciences." Harvard Business School Case 402-026, October 2001. (Revised March 2002.)
    • August 1985 (Revised May 1986)
    • Case

    BioTechnica International

    By: Ray A. Goldberg
    Keywords: Biotechnology Industry
    Citation
    Find at Harvard
    Related
    Goldberg, Ray A. "BioTechnica International." Harvard Business School Case 586-014, August 1985. (Revised May 1986.)
    • ←
    • 15
    • 16
    • …
    • 31
    • 32
    • →
    ǁ
    Campus Map
    Harvard Business School
    Soldiers Field
    Boston, MA 02163
    →Map & Directions
    →More Contact Information
    • Make a Gift
    • Site Map
    • Jobs
    • Harvard University
    • Trademarks
    • Policies
    • Accessibility
    • Digital Accessibility
    Copyright © President & Fellows of Harvard College.